Bakuchiol body oil sold in the USA is regulated by the FDA as a cosmetic product under the Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Modernization of Cosmetics Regulation Act of 2023 (MoCRA). It is not regulated as a drug unless the product makes drug-level claims (e.g., "treats acne," "reduces fine lines" phrased as a therapeutic outcome rather than a cosmetic appearance claim). Staying on the right side of this line is critical.
Required label elements for a cosmetic body oil sold in the USA:
1. Identity of product (e.g., "Bakuchiol Body Oil") — must appear on the principal display panel. 2. Net quantity of contents — fill volume in fluid ounces and milliliters (e.g., "1 fl oz / 30 ml"). 3. Name and address of the manufacturer, packer, or distributor — your brand's US business address. 4. Ingredient list in descending order of predominance using INCI (International Nomenclature of Cosmetic Ingredients) names. Bakuchiol is listed as "Bakuchiol" in INCI. Carrier oils are listed by their INCI names (e.g., "Simmondsia Chinensis (Jojoba) Seed Oil," "Rosa Canina Fruit Oil" for rosehip). 5. Any required warnings — for example, "Keep out of reach of children," or flammability warnings if the formula has a flash point below certain thresholds.
Under MoCRA (effective 2024 and rolling deadlines through 2025), manufacturers must also: — Register their facility with the FDA — List each cosmetic product formulation with the FDA — Maintain safety substantiation records — Report serious adverse events to the FDA within 15 business days
Claims to avoid on a bakuchiol body oil label in the USA: "retinol alternative" is a gray area that has drawn FDA scrutiny because it may imply drug-like activity. "Visibly reduces the appearance of fine lines" is generally acceptable as a cosmetic claim. "Clinically proven to reduce wrinkles" is a higher-risk claim that requires substantiation data.
If you intend to sell in the EU, bakuchiol is not a restricted ingredient under Annex II, III, or IV of the EU Cosmetics Regulation (EC 1223/2009), so it can be used freely. However, any fragrance components must disclose allergens present at >0.001% in leave-on products, and you will need a CPSR and PIF.
Always have your INCI list and label copy reviewed by a qualified cosmetic regulatory consultant or attorney before going to market. Your manufacturer may offer this as a service — or AJ Cosmo Labs can connect you with independent regulatory consultants on the platform.
Read the full guide on Private Label Bakuchiol Body Oil Manufacturer USA Low MOQ →